Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PSMA-PET Directed Radiation Therapy in High and Very High-Risk Prostate Cancer

NCT07291557 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.

NCT NCT07291557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07291557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PSMA-PET Directed Radiation Therapy in High and Very High-Risk Prostate Cancer
Lead sponsor
AHS Cancer Control Alberta
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
May 31, 2036
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer